(Q33492940)

27 July 2017

Repeat administration of high dose melphalan in relapsed myeloma (English)

1 reference

27 July 2017

2

Cunningham D

1 reference

27 July 2017

Mansi JL

1

1 reference

27 July 2017

Viner C

3

1 reference

27 July 2017

Ellis E

4

1 reference

27 July 2017

Meldrum M

5

1 reference

27 July 2017

Milan S

6

1 reference

27 July 2017

Gore M

7

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

British Journal of Cancer

27 July 2017

1 reference

27 July 2017

68

1 reference

27 July 2017

5

1 reference

27 July 2017

983-987

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.466

27 July 2017

0 references

cites work

The current status and future prospects of treatment for multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisolone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

High-dose chemotherapy and autologous bone marrow transplantation for myeloma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968739

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

21 June 2018

1 reference

12 December 2020

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

1 reference

12 December 2020

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.466

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference